Ulrika Logren

Papers

Total Citations

H-Index

About

Ulrika Logren is a distinguished analytical chemist whose work has significantly advanced bioanalytical methodology, particularly in the field of drug metabolism and pharmacokinetics. Her research focuses on the development and validation of highly sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) techniques for quantifying pharmaceutical compounds and their metabolites in biological matrices. Her most-cited work, "Determination of ximelagatran, melagatran and two intermediary metabolites in plasma by mixed-mode solid phase extraction and LC–MS/MS" (2007, 14 citations), exemplifies her expertise in creating robust, mixed-mode solid-phase extraction methods that enable precise, simultaneous measurement of parent drugs and their active metabolites. This contribution is critical for understanding drug bioavailability, metabolic pathways, and therapeutic efficacy. Logren’s methodological innovations have provided essential tools for preclinical and clinical studies, ensuring accurate pharmacokinetic profiling. Her work is particularly notable for its practical impact on drug development, offering reliable analytical solutions that support safer and more effective therapeutics. Through her meticulous approach, Logren has established herself as a key figure in bioanalytical chemistry, influencing both academic research and pharmaceutical industry practices.